Virtual Medicinal Product (VMP) - Betamethasone 0.1% / Neomycin 0.5% ear/eye/nose drops
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Betamethasone 0.1% / Neomycin 0.5% ear/eye/nose drops | Start Date 25-06-2010 | End Date |
Previous Name | Previous Name Neomycin 0.5% / Betamethasone 0.1% ear/eye/nose drops | Start Date 03-12-2002 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Ocular, Auricular, Nasal
- Form
- Ear/eye/nose drops solution
- Ontology Form/Route
- solutiondrops.ophthalmic, solutiondrops.auricular, solutiondrops.nasal
- Name Basis
- Other
Codes
- ATC Code
- S03CA06
BNF | Start Date | End Date |
---|---|---|
Current BNF 12010100 | Start Date 04-04-2022 | End Date |
Previous BNF 12020300 | Start Date 23-02-2005 | End Date 03-04-2022 |
Previous BNF 11040100 | Start Date 15-02-2005 | End Date 03-04-2022 |
Previous BNF 12010100 | Start Date 15-02-2005 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
42185211000001105 | 25-08-2023 | |
330953008 | 03-12-2002 | 24-08-2023 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Betamethasone sodium phosphate | Based on Base Substance | Betamethasone | 1 mg | 1 ml |
Neomycin sulfate | Based on Ingredient Substance | 5 mg | 1 ml |
Name
Neomycin sulfate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5.0
Strength and UOM (Dmr)
1.0
Name
Betamethasone sodium phosphate
Basis of strength description
Based on Base Substance
BOSS
Betamethasone
Strength and UOM (Nmr)
1.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMBetamethasone + Neomycin
-
VMP(Current) Betamethasone 0.1% / Neomycin 0.5% e...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
5 ml | ||
10 ml | 239 | Part VIIIA Category C |